Targeting the A₃ adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice

Medicine & Life Sciences

• Adenosine A3 Receptors 100%
• Cisplatin 56%
• Drug Therapy 36%
• Cognitive Dysfunction 15%
• Genes 7%
• Spatial Memory 6%
• Oligodendroglia 6%
• Hyperalgesia 6%
• Memory Disorders 6%
• Peripheral Nervous System Diseases 6%
• Executive Function 6%
• Neuralgia 6%
• Microglia 6%
• Short-Term Memory 5%
• Astrocytes 5%
• In Situ Hybridization 5%
• Chromatin 5%
• Oxidative Stress 4%
• Up-Regulation 4%
• Clinical Trials 4%
• Neoplasms 4%
• Neurons 3%
• Pain 3%
• Messenger RNA 3%
• Therapeutics 3%
• Brain 3%